136 related articles for article (PubMed ID: 25662418)
1. B-cell depletion in immune thrombocytopenia.
Psaila B; Cooper N
Lancet; 2015 Apr; 385(9978):1599-601. PubMed ID: 25662418
[No Abstract] [Full Text] [Related]
2. [Commentary on "Rituximab in thrombocytopenic purpura..."].
García-Álvarez JL
Rev Med Inst Mex Seguro Soc; 2012; 50(4):351-2. PubMed ID: 23234734
[No Abstract] [Full Text] [Related]
3. [Reply to commentary on "Rituximab in thrombocytopenic purpura..."].
Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
Rev Med Inst Mex Seguro Soc; 2012; 50(4):353-4. PubMed ID: 23234735
[No Abstract] [Full Text] [Related]
4. Successful treatment of refractory immune thrombocytopenia with rituximab in a 10-week-old infant.
Gray C; Kalumba K; Pati N; Peterson A; Connell TG
J Pediatr Hematol Oncol; 2013 May; 35(4):e174-7. PubMed ID: 23459375
[TBL] [Abstract][Full Text] [Related]
5. [Use of rituximab in resistant thrombocytopenic purpura].
Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
Rev Med Inst Mex Seguro Soc; 2012; 50(2):203-8. PubMed ID: 22882991
[TBL] [Abstract][Full Text] [Related]
6. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.
Shores D; Kobak G; Pegram LD; Whitington PF; Shneider BL
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):e128-30. PubMed ID: 21921813
[No Abstract] [Full Text] [Related]
7. Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
Zwaginga JJ; van der Holt B; Te Boekhorst PA; Biemond BJ; Levin MD; van der Griend R; Brand A; Zweegman S; Pruijt HF; Novotny VM; Vreugdenhil A; de Groot MR; de Weerdt O; van Pampus EC; van Maanen-Lamme TM; Wittebol S; Schipperus MR; Silbermann MH; Huijgens PC; Luten M; Hollestein R; Brakenhoff JA; Schrama JG; Valster FA; Velders GA; Koene HR;
Haematologica; 2015 Mar; 100(3):e90-2. PubMed ID: 25425692
[No Abstract] [Full Text] [Related]
8. Rituximab for patients with idiopathic thrombocytopenic purpura.
Peñalver FJ; Cabrera JR
Ann Intern Med; 2007 Aug; 147(4):281; author reply 281-2. PubMed ID: 17709765
[No Abstract] [Full Text] [Related]
9. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
Gall B; Yee A; Berry B; Bircham D; Hayashi A; Dansereau J; Hart J
J Obstet Gynaecol Can; 2010 Dec; 32(12):1167-1171. PubMed ID: 21176329
[TBL] [Abstract][Full Text] [Related]
10. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
[No Abstract] [Full Text] [Related]
11. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
[TBL] [Abstract][Full Text] [Related]
12. Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia.
Zeller M; Arnold DM
Am J Hematol; 2015 Apr; 90(4):271-2. PubMed ID: 25677795
[No Abstract] [Full Text] [Related]
13. Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.
Oo TH
South Med J; 2005 Dec; 98(12):1227-8. PubMed ID: 16440930
[No Abstract] [Full Text] [Related]
14. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.
Roganovic J
Eur J Pediatr; 2005 May; 164(5):334. PubMed ID: 15711954
[No Abstract] [Full Text] [Related]
15. Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman.
Martínez-Martínez MU; Baranda-Cándido L; González-Amaro R; Pérez-Ramírez O; Abud-Mendoza C
Rheumatology (Oxford); 2013 Feb; 52(2):405-6. PubMed ID: 22772325
[No Abstract] [Full Text] [Related]
16. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
Toubi E
Harefuah; 2012 Nov; 151(11):620-1, 655. PubMed ID: 23367731
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for adult primary immune thrombocytopenia.
Frederiksen H
Lancet Haematol; 2015 Feb; 2(2):e52-3. PubMed ID: 26687609
[No Abstract] [Full Text] [Related]
18. [Immunologic mechanisms involved in rituximab failure during adult immune thrombocytopenia].
Audia S; Saas P; Bonnotte B
Med Sci (Paris); 2014 Mar; 30(3):239-42. PubMed ID: 24685209
[No Abstract] [Full Text] [Related]
19. A case of rituximab-induced hepatitis.
Del Prete CJ; Cohen NS
Cancer Biother Radiopharm; 2010 Dec; 25(6):747-8. PubMed ID: 21204770
[TBL] [Abstract][Full Text] [Related]
20. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
Aleem A
Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
